Spire Healthcare Group plc
SPI.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £1,511,200 | £1,359,000 | £1,198,500 | £1,106,200 |
| % Growth | 11.2% | 13.4% | 8.3% | – |
| Cost of Goods Sold | £827,600 | £838,400 | £758,000 | £712,100 |
| Gross Profit | £683,600 | £520,600 | £440,500 | £394,100 |
| % Margin | 45.2% | 38.3% | 36.8% | 35.6% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £394,100 | £336,300 | £312,900 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £546,100 | £0 | £0 | £0 |
| Operating Expenses | £546,100 | £394,100 | £336,300 | £312,900 |
| Operating Income | £137,500 | £126,500 | £104,200 | £81,200 |
| % Margin | 9.1% | 9.3% | 8.7% | 7.3% |
| Other Income/Exp. Net | -£99,200 | -£91,900 | -£100,300 | -£83,100 |
| Pre-Tax Income | £38,300 | £34,600 | £3,900 | -£1,900 |
| Tax Expense | £12,300 | £6,700 | -£4,300 | £7,000 |
| Net Income | £25,400 | £27,300 | £8,600 | -£9,700 |
| % Margin | 1.7% | 2% | 0.7% | -0.9% |
| EPS | 0.063 | 0.068 | 0.021 | -0.024 |
| % Growth | -6.8% | 215.9% | 188.4% | – |
| EPS Diluted | 0.062 | 0.066 | 0.021 | -0.024 |
| Weighted Avg Shares Out | 403,493 | 403,649 | 402,679 | 400,848 |
| Weighted Avg Shares Out Dil | 411,393 | 413,144 | 412,043 | 400,848 |
| Supplemental Information | – | – | – | – |
| Interest Income | £700 | £1,400 | £0 | £87,000 |
| Interest Expense | £98,400 | £93,000 | £91,500 | £87,000 |
| Depreciation & Amortization | £112,200 | £103,600 | £97,900 | £97,100 |
| EBITDA | £250,400 | £231,200 | £193,300 | £182,200 |
| % Margin | 16.6% | 17% | 16.1% | 16.5% |